New Medicines Legislation
This article was originally published in SRA
Sweden in process of transposing three EU directives
You may also be interested in...
The pandemic may accelerate a move toward versatile, single-solution renal replacement therapy in intensive care.
The US agency has announced another month of webinars aimed at labs and manufacturers that are developing – or have developed – diagnostic tests for the novel coronavirus.
The European Medicines Agency says its rolling review tool should speed up the evaluation of AstraZeneca’s COVID-19 vaccine.